The Alignment of Real-World Evidence and Digital Health: Realising the Opportunity
- PMID: 33914297
- PMCID: PMC8082742
- DOI: 10.1007/s43441-021-00288-7
The Alignment of Real-World Evidence and Digital Health: Realising the Opportunity
Abstract
In the new era of healthcare digitalization, there is a golden opportunity in the overlap between digital health and Real-World Evidence (RWE). In this commentary, we define RWE and digital health and investigate their intersection. We describe the stages in the RWE value chain critical to the evidence generation process, how these stages change with new digital technologies and the opportunities and challenges that arise from how these stages evolve-including their application for stakeholders such as patients, physicians and regulators. We also discuss the current published guidelines and frameworks regarding digital health. We categorise these publications in terms of their clarity as "Extensive", "Intermediate" or "Basic" and according to whether they encompass all levels of digital health or are more focussed in their guidance. Finally, we provide recommendations to increase synergy between RWE and digital health.
Keywords: Digital health; Guidelines; Health data; Real-Word Data; Real-World Evidence; Wearables.
Conflict of interest statement
The Real-World Evidence Leadership Forum, which consists of senior RWE executives from 16 major pharmaceutical companies, works as a non-compete collaborative to understand, discuss and respond to internal and external RWE challenges and opportunities with a single expert voice, with the aim of improving outcomes for patients globally. Johan Liwing is an employee and shareholder of XNK Therapeutics and declares no other Competing Financial or Non-Financial interests. Sajan Khosla is an employee and shareholder of AstraZeneca and declares no other Competing Financial or Non-Financial interests. Feudjo Tepie is an employee of Amgen Ltd and owns shares of Amgen Inc. Mark Nagy is an employee of Eli Lilly and Company and owns shares or stock in Eli Lilly and Company. George Kafatos is an employee of Amgen Ltd and owns shares of Amgen Inc. Michael Seewald declares no Competing Financial or Non-Financial Interests. Stephanie Marchese is an employee of a company that produces real-world evidence for regulatory and other purposes.
Figures
References
-
- Breaking New Ground with RWE: How some pharmacos are poised to realize a $1 billion opportunity. https://www.iqvia.com/-/media/quintilesims/pdfs/qims_breaking_new_ground.... Accessed 07 Mar 2021.
-
- European Commission. https://ec.europa.eu/health/ehealth/overview_en. Accessed 23 Aug 2019.
-
- WHO. WHO Guideline: Recommendations on Digital Interventions for Health System Strengthening; 2019. https://www.who.int/publications-detail/who-guideline-recommendations-on.... Accessed 23 Aug 2019. - PubMed
-
- Lexico Dictionary. 2019. https://www.lexico.com/. Accessed 23 Aug 2019.
-
- ICMRA Innovation strategic Priority Report. http://icmra.info/drupal/sites/default/files/2019-04/Innovation%20Strate.... Accessed 15 Mar 2019.
LinkOut - more resources
Full Text Sources
Other Literature Sources
